Testing and Treatment of Latent Tuberculosis Infection in the United States: Clinical Recommendations
LTBI | Features | TB | CDC
Home
Curry International Tuberculosis Center | San Francisco CA
TB Center Products
Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)
National Tuberculosis Controllers Association
Home
National Tuberculosis Controllers Association
michael lauzardo university of florida | National Tuberculosis Controllers Association
Changing TB Isolation Practices: New Guidelines for Molecular Testing - YouTube
PDF) Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
Social Media | Infographics | Publications & Products | TB | CDC
Moving Forward to TB Elimination: NTCA's Role
2021 CDC U.S. TB Elimination Champions | U.S.TB Champions | World TB Day | TB | CDC
Department of Public Health's Chima Mbakwem is Named the National Tuberculosis Controller of the year 2022 - PNC News First
CDC, NTCA issue update on TB screening, testing and treatment | AHA News
SE TB Controllers Meeting October 6, 2016
National Tuberculosis Controllers Association
Curry International Tuberculosis Center | San Francisco CA
National Tuberculosis Controllers Association
Vanderbilt TB Center wins Joe B. Ware Partner Service Award | Vanderbilt Tuberculosis Center
Community of Practice | National Tuberculosis Controllers Association
Nitrosamines and Rifamycins: A Primer for TB Nurses | National Tuberculosis Controllers Association
State/Big City/Territory | National Tuberculosis Controllers Association
